Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies
- 25 March 2003
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 82 (4) , 218-222
Abstract
The study was performed to describe the time course of serum cardiac troponin T (cTnT) elevations for the early detection of anthracycline cardiotoxicity. cTnT was analyzed serially in 78 patients with hematological malignancies receiving 142 treatment cycles including various anthracyclines. cTnT positivity was defined as an increase in cTnT ≥0.03 ng/ml and was observed in 12 patients (15%) during 16 treatment cycles (11%). Peak cTnT levels were observed on day +21.5 (median, range: day +6 to day +35) after initiation of anthracycline therapy. cTnT positivity lasted ≥3 days in 63% of cycles and began to occur after a median of two anthracycline doses. Follow-up echocardiography in 28 patients showed a greater decrease in left ventricular ejection fraction (LVEF) in cTnT-positive patients compared to the cTnT-negative group (10% vs 2%, p=0.017). Age, gender, and pretreatment LVEF had no influence on the occurrence of cTnT positivity. Serial measurement of serum cTnT reveals delayed subclinical myocardial damage even after minor anthracycline exposure, may identify patients at risk for subsequent myocardial dysfunction, and suggests prolonged damage to the cardiac myofibrillar system.Keywords
This publication has 9 references indexed in Scilit:
- Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamideEuropean Journal of Haematology, 2002
- Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapyAnnals of Oncology, 2002
- Troponin T in the first 24 hours after the administration of chemotherapy and the detection of myocardial damage in childrenEuropean Journal of Cancer, 2002
- Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomyopathy Induced by DoxorubicinJournal of Clinical Oncology, 1999
- Doxorubicin-Induced CardiomyopathyNew England Journal of Medicine, 1998
- Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial InjuryCirculation, 1997
- Interaction of anthracyclinic antibiotics with cytoskeletal components of cultured carcinoma cells (CG5)Experimental and Molecular Pathology, 1990
- Cardiotoxicity Associated With High-Dose Cyclophosphamide TherapyArchives of internal medicine (1960), 1981
- Cardiac pathologic findings in patients treated with bone marrow transplantationHuman Pathology, 1976